Correction to “Reregulated Mitochondrial Dysfunction Reverses Cisplatin Resistance Microenvironment in Colorectal Cancer”
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCancer therapeutics and mechanisms · DNA Repair Mechanisms · Drug Transport and Resistance Mechanisms
Y. Wang, X. Ma, W. Zhou, C. Liu, H. Zhang, Reregulated mitochondrial dysfunction reverses cisplatin resistance microenvironment in colorectal cancer. Smart Med. 2022, 1(1), e20220013.
In this article, the full name of TCPP should be Tetra(4‐carboxyphenyl)porphyrin, but the article incorrectly refers to it as Tris(2‐chloroisopropyl) phosphate in several instances. This error appears in four locations:
- The abstract on the first page
- The list of abbreviations on the first page
- The final part of the introduction on the third page
- The caption of Figure 1 on the sixth page
We apologize for this error.